Aspira Women’s Health (NYSE:AWH) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Aspira Women’s Health (NYSE:AWH – Get Rating) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the stock.

Aspira Women’s Health Trading Up 1.9 %

Shares of NYSE AWH opened at $0.58 on Tuesday. The company has a market capitalization of $72.39 million, a PE ratio of -2.15 and a beta of 2.89. Aspira Women’s Health has a fifty-two week low of $0.29 and a fifty-two week high of $1.29. The company’s 50-day moving average is $0.42.

Aspira Women’s Health (NYSE:AWH – Get Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.03. The company had revenue of $2.07 million during the quarter, compared to analysts’ expectations of $2.40 million.

About Aspira Women’s Health

(Get Rating)

Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.